ICAM3 and neoplasm: Furthermore, Darom A et al. analyzed 36 cases of B-cell MALT-type primary gastric lymphomas and identified ICAM3, along with PECAM-1 and HLA-DR, as markers of tumor expansion potential and host immune surveillance, respectively.